Don't let NASH be your silent partner.
The NATiV3 Study is now enrolling.
NASH (non-alcoholic steatohepatitis) is the result of fat buildup and inflammation in the liver, which can cause serious health hazards. If you have been diagnosed with NASH or liver fibrosis, you may be eligible to participate in a clinical study evaluating an investigational treatment.
To see if the NATiV3 Study is right for you, please contact us.
Location: MNGI Digestive Health, Northeast Minneapolis Clinic
Physician Investigator: Dr. Hanouneh
Study Coordinator: Naomi Mugarura